| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 10/06/1999 | EP0946545A1 Novel carboxy substituted cyclic carboxamide derivatives |
| 10/06/1999 | EP0946541A1 Quinolines and their therapeutic use |
| 10/06/1999 | EP0946524A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists |
| 10/06/1999 | EP0946523A1 Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| 10/06/1999 | EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 10/06/1999 | EP0946201A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation |
| 10/06/1999 | EP0946175A1 USE OF AN H+, K+ -ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS |
| 10/06/1999 | CN1045443C Novel purine derivatives and pharmaceutically acceptable salts thereof |
| 10/06/1999 | CN1045435C Naphthalene derivative, preparation thereof and middle agent syntherised of same |
| 10/05/1999 | US5962707 19-nor-vitamin D3 compounds with calcemic activity |
| 10/05/1999 | US5962666 Polynucleotide or its complement which codes for enzyme involved in bacterial protein synthesis; for diagnosis and treatment of chlamydia infections such as urogenital disorders and vision defects; bactericides |
| 10/05/1999 | US5962492 Antiasthma agents; antiinflammatory agents |
| 10/05/1999 | US5962490 Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 10/05/1999 | US5962483 Antiasthma agents; antiinflammatory agents |
| 10/05/1999 | US5962479 Psychological and nervous sytem disorders |
| 10/05/1999 | US5962464 Side effect reduction |
| 10/05/1999 | US5962445 Treatment of asthma and airway diseases |
| 10/05/1999 | US5962422 Inhibition of selectin binding |
| 10/05/1999 | CA2195924C 3-aza and 3-oxa-piperidone tachykinin antagonists |
| 09/30/1999 | WO1999049039A2 GFRα3 AND ITS USES |
| 09/30/1999 | WO1999048925A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 09/30/1999 | WO1999048871A1 Pyridine derivative and pharmaceutical containing the same |
| 09/30/1999 | WO1999048476A1 Improved compositions for inhalation |
| 09/30/1999 | WO1999048361A1 Xylitol compositions for treating upper respiratory conditions |
| 09/30/1999 | WO1999038877A3 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES |
| 09/30/1999 | WO1999038532A3 Methods for the prevention and treatment of fibrosis and sclerosis |
| 09/30/1999 | WO1999035266A3 Human urotensin ii |
| 09/30/1999 | WO1999032449A3 Benzazine derivatives as phosphodiesterase 4 inhibitors |
| 09/30/1999 | WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 09/30/1999 | CA2325584A1 Improved compositions for inhalation |
| 09/30/1999 | CA2324340A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 09/29/1999 | EP0945464A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 09/29/1999 | EP0944636A1 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS |
| 09/29/1999 | EP0944630A1 Xanthines and their therapeutic use |
| 09/29/1999 | EP0944622A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944620A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944618A1 Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use |
| 09/29/1999 | EP0944616A1 Bicyclic aryl carboxamides and their therapeutic use |
| 09/29/1999 | EP0944614A1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them |
| 09/29/1999 | EP0944606A1 4,5-diaminopyrimidine derivatives and a method for the preparation thereof |
| 09/29/1999 | EP0944604A1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944601A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944599A1 Triarylethanes useful as pde iv inhibitors |
| 09/29/1999 | EP0944592A1 Vitamin d3 derivatives |
| 09/29/1999 | CN1230196A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn. |
| 09/29/1999 | CN1230186A Pyrazolopyridine compound and pharmaceutical use thereof |
| 09/29/1999 | CN1230174A Benzamidine derivatives and use thereof as medicaments with LTB4-antagonistic effect |
| 09/29/1999 | CN1230110A Cell adhesion inhibitors |
| 09/28/1999 | US5959123 Reacating substituted amino acid with 3-amino-4-substituted-azetidine-2-one compound to form 3, 4-disubstituted-azetidine-2-one compound; useful for treating muscular dystrophy, arthritis, viral and parasitic infections |
| 09/28/1999 | US5958953 Substituted indazole derivatives |
| 09/28/1999 | US5958943 A!-anellated pyrrole derivatives and their use in pharmacology |
| 09/28/1999 | US5958926 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 09/28/1999 | US5958905 Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin |
| 09/28/1999 | US5958897 Method of treating sinusitis with uridine triphosphates and related compounds |
| 09/28/1999 | US5958891 Administering vector comprising gene encoding dust mite allergen by intramuscular injection to prevent airway hyperreactivity or airway inflammation |
| 09/28/1999 | US5958427 Locally dilating blood vessels in a mammal by administering a nonpolymeric mucosally impermeant nitric oxide donor compound selected from the group of a tertiary amino or quaternary amino nitric oxide donor; male impotence, aphrodisiac |
| 09/28/1999 | US5958401 Method of using IL-11 for treating psoriasis |
| 09/23/1999 | WO1999047547A1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 09/23/1999 | WO1999047512A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 09/23/1999 | WO1999047505A1 Phthalazinone pde iii/iv inhibitors |
| 09/23/1999 | WO1999047132A2 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 09/23/1999 | WO1999041369A3 Genetic vaccine vector engineering |
| 09/23/1999 | WO1999033859A9 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 09/23/1999 | CA2323771A1 Phthalazinone pde iii/iv inhibitors |
| 09/23/1999 | CA2322742A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/23/1999 | CA2321155A1 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 09/22/1999 | EP0943616A1 Substituted imidazole derivatives and their use as cytokine inhibitors |
| 09/22/1999 | EP0943606A1 Benzenesulfonamide derivatives and drugs containing the same |
| 09/22/1999 | EP0943338A1 Treatment of pulmonary disease |
| 09/22/1999 | EP0942984A2 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE) |
| 09/22/1999 | EP0942979A2 Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders |
| 09/22/1999 | EP0942974A2 Secreted proteins and polynucleotides encoding them |
| 09/22/1999 | EP0942902A2 Novel immunotherapeutic imides/amides |
| 09/22/1999 | EP0942896A1 Substituted phenols and thiophenols useful as antioxidant agents |
| 09/22/1999 | EP0942723A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 09/22/1999 | EP0726764B1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 09/22/1999 | EP0706507B1 Salmeterol xinafoate with controlled particle size |
| 09/22/1999 | CN1229407A Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same |
| 09/22/1999 | CN1229405A Novel acetamide derivatives and protease inhibitors |
| 09/22/1999 | CN1228992A Antipyretic granular formulation containing ramulus cinnamomi, ephedra and bupleurum root |
| 09/22/1999 | CN1228990A Prescription of antasthmatic powder and preparation method thereof |
| 09/22/1999 | CN1228967A Traditional Chinese medicine preparation for treating nasal meatus disease and cataract |
| 09/21/1999 | US5955492 Carboxylic acid indole inhibitors of chemokines |
| 09/21/1999 | US5955457 Water soluble rapamycin esters |
| 09/21/1999 | US5955442 Methods for treating respiratory disease |
| 09/21/1999 | US5955365 Introducing polynucleotides into cells |
| 09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |
| 09/21/1999 | US5955308 cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor |
| 09/21/1999 | US5955089 Streptococcus for vaccines |
| 09/21/1999 | US5955058 Stabilized medicinal aerosol solution formulations containing ipratropium bromide |
| 09/21/1999 | CA2045761C Ws7622a mono- or di- sulfate, process for preparation thereof and use thereof |
| 09/16/1999 | WO1999046289A1 31 human secreted proteins |
| 09/16/1999 | WO1999046272A1 Serine peptidase modulators |
| 09/16/1999 | WO1999046268A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 09/16/1999 | WO1999046248A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 09/16/1999 | WO1999046237A1 Modulators of protein tyrosine phosphatases |
| 09/16/1999 | WO1999045941A1 Peptide compositions and formulations and use of same |
| 09/16/1999 | WO1999045916A2 Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are affected |
| 09/16/1999 | WO1999045915A1 Use of alpha-rar antagonists for inhibition of mucin secretion |
| 09/16/1999 | WO1999045777A1 Compositions and methods for treatment of asthma |